Morise M - Search Results

1

[A case of possible retroperitoneal metastasis of breast cancer successfully treated with oral S-1 and cyclophosphamide therapy after TC therapy].

Yoneyama K, Takeshita T, Suzuki H, Morise M, Suzuki T, Kishi S, Tsutsui A, Matsumoto A. Yoneyama K, et al. Among authors: morise m. Gan To Kagaku Ryoho. 2011 Mar;38(3):435-7. Gan To Kagaku Ryoho. 2011. PMID: 21403449 Japanese.

2

[A case of local-recurring breast cancer under long term-treatment by capecitabine].

Yoneyama K, Takeshita T, Suzuki H, Morise M, Suzuki T, Kishi S, Tsutsui A, Matsumoto A. Yoneyama K, et al. Among authors: morise m. Gan To Kagaku Ryoho. 2011 Dec;38(13):2623-5. Gan To Kagaku Ryoho. 2011. PMID: 22189229 Japanese.

3

[Usefulness of the stent through percutaneous endoscopic gastrostomy for pyloric stenosis].

Beck E, Moriya H, Kuroyama S, Morise M, Kobayashi N, Shimao H, Watanabe M. Beck E, et al. Among authors: morise m. Gan To Kagaku Ryoho. 2006 Dec;33 Suppl 2:288-90. Gan To Kagaku Ryoho. 2006. PMID: 17469363 Japanese.

4

Gastric cancer with metastases to the distant peritoneum: a 20-year surgical experience.

Kikuchi S, Arai Y, Morise M, Kobayashi N, Tsukamoto H, Shimao H, Sakakibara Y, Hiki Y, Kakita A. Kikuchi S, et al. Among authors: morise m. Hepatogastroenterology. 1998 Jul-Aug;45(22):1183-8. Hepatogastroenterology. 1998. PMID: 9756030

5

Femoral bone metastasis is a poor prognostic factor in EGFR-TKIs-treated patients with EGFR-mutated non-small-cell lung cancer: a retrospective, multicenter cohort study.

Tanaka I, Hori K, Koyama J, Gen S, Morise M, Kodama Y, Matsui A, Miyazawa A, Hase T, Hibino Y, Yokoyama T, Kimura T, Yoshida N, Sato M, Ishii M. Tanaka I, et al. Among authors: morise m. Ther Adv Med Oncol. 2024 Dec 20;16:17588359241303090. doi: 10.1177/17588359241303090. eCollection 2024. Ther Adv Med Oncol. 2024. PMID: 39712073 Free PMC article.

6

Artificial intelligence-based personalized survival prediction using clinical and radiomics features in patients with advanced non-small cell lung cancer.

Koyama J, Morise M, Furukawa T, Oyama S, Matsuzawa R, Tanaka I, Wakahara K, Yokota H, Kimura T, Shiratori Y, Kondoh Y, Hashimoto N, Ishii M. Koyama J, et al. Among authors: morise m. BMC Cancer. 2024 Nov 18;24(1):1417. doi: 10.1186/s12885-024-13190-w. BMC Cancer. 2024. PMID: 39558311 Free PMC article.

7

Clinical Significance of a Prospective Large Genomic Screening for SCLC: The Genetic Classification and a Biomarker-Driven Phase 2 Trial of Gedatolisib.

Umemura S, Udagawa H, Ikeda T, Murakami H, Daga H, Toyozawa R, Kozuki T, Sakakibara-Konishi J, Ohe Y, Morise M, Kato T, Shingyoji M, Hara S, Furuya N, Teranishi S, Takata S, Miyamoto S, Nakachi I, Wakabayashi M, Nomura S, Sato A, Ishii G, Tsuchihara K, Sugiyama E, Kirita K, Sakai T, Shibata Y, Izumi H, Nosaki K, Zenke Y, Matsumoto S, Yoh K, Niho S, Goto K. Umemura S, et al. Among authors: morise m. J Thorac Oncol. 2024 Oct 10:S1556-0864(24)02378-5. doi: 10.1016/j.jtho.2024.10.004. Online ahead of print. J Thorac Oncol. 2024. PMID: 39395663

8

Diagnostic Value and Safety of Addition of Transbronchial Needle Aspiration to Transbronchial Biopsy Through Endobronchial Ultrasonography Using a Guide Sheath Under Virtual Bronchoscopic Navigation for the Diagnosis of Peripheral Pulmonary Lesions.

Ito T, Nishida K, Iwano S, Okachi S, Nakamura S, Morise M, Yoshikawa Fengshi Toyofumi C, Ishii M. Ito T, et al. Among authors: morise m. J Bronchology Interv Pulmonol. 2024 Sep 13;31(4):e0984. doi: 10.1097/LBR.0000000000000984. eCollection 2024 Oct 1. J Bronchology Interv Pulmonol. 2024. PMID: 39268930

9

Tepotinib plus osimertinib in patients with EGFR-mutated non-small-cell lung cancer with MET amplification following progression on first-line osimertinib (INSIGHT 2): a multicentre, open-label, phase 2 trial.

Wu YL, Guarneri V, Voon PJ, Lim BK, Yang JJ, Wislez M, Huang C, Liam CK, Mazieres J, Tho LM, Hayashi H, Nhung NV, Chia PL, de Marinis F, Raskin J, Zhou Q, Finocchiaro G, Le AT, Wang J, Dooms C, Kato T, Nadal E, Hin HS, Smit EF, Wermke M, Tan D, Morise M, O'Brate A, Adrian S, Pfeiffer BM, Stroh C, Juraeva D, Strotmann R, Goteti K, Berghoff K, Ellers-Lenz B, Karachaliou N, Le X, Kim TM; INSIGHT 2 investigators. Wu YL, et al. Among authors: morise m. Lancet Oncol. 2024 Aug;25(8):989-1002. doi: 10.1016/S1470-2045(24)00270-5. Lancet Oncol. 2024. PMID: 39089305 Clinical Trial.

10

Phase II study of brigatinib in patients with ROS1 fusion-positive non-small-cell lung cancer: the Barossa study.

Niho S, Goto Y, Toyozawa R, Daga H, Ohashi K, Takahashi T, Tanaka H, Sakakibara-Konishi J, Hattori Y, Morise M, Kodani M, Ikeda T, Izumi H, Matsumoto S, Yoh K, Nomura S, Goto K. Niho S, et al. Among authors: morise m. ESMO Open. 2024 Aug;9(8):103642. doi: 10.1016/j.esmoop.2024.103642. Epub 2024 Jul 16. ESMO Open. 2024. PMID: 39018589 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

107 results

Search Page

Filters